Navigation Links
Clinical Trials for a Low-dose Steroid Therapy for Bone Marrow Cancer Prove Positive

Researchers see hopes in a new therapy combining low dose steroid with lenalidomide, already// found effective against multiple myeloma.

Multiple myeloma is a cancer of plasma cells that are found in blood and bone marrow.

Survival chances improved considerably when a low dose of the steroid dexamethasone combined with lenalidomide was tried on patients with newly diagnosed multiple myeloma.

The clinical trial was sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and conducted by a network of researchers led by the Eastern Cooperative Oncology Group (ECOG).

The significance of the results lies in that a low dose regimen has been found to be more effective than the standard dose of dexamethasone.

Researchers found that patients in the study who received a lower dose regimen had a one-year survival of 96 percent compared to 86 per cent for patients treated in the case of those with the standard-dose of dexamethasone and lenalidomide.

In addition, there were fewer side effects associated with the low-dose dexamethasone and lenalidomide.

"These results have major implications for myeloma therapy," noted study chair Vincent Rajkumar. "The results of this study, particularly lenalidomide plus low-dose dexamethasone, are very positive and in my opinion represent a real step forward in the treatment of this disease."

The application of this effective and less toxic approach is expected to benefit many patients with myeloma.

In 2007, an estimated 19,900 people in the United States will be diagnosed with multiple myeloma and an estimated 10,790 people will die of the disease.
SRM
'"/>




Page: 1

Related medicine news :

1. Clinical trials need to be more frank
2. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
3. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
4. Clinical Comparisons Between ADHD Drugs Are Less
5. A Novel System For Clinical Banking Of Umbilical Cord Blood
6. Clinical Renal Trails Do Not Have Sufficient Women Participants
7. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
8. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
9. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
10. Cancer Clinical Research in India
11. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
Post Your Comments:
(Date:1/9/2009)..., BELGIUM, Wis., Jan. 9 /PRNewswire-FirstCa...a biological solutions company that develops produ...the agricultural and consumer,market, announced t... of,intent dated January 7, 2009 related to a pro.... (the "Seller") to acquire all of the outstanding...
(Date:1/9/2009)..., Biocoat, Inc., Horsham,...g has recently been created and linked to the comp...device manufacturers and designers can go to find ...gies and post information and related coatings new...January 9, 2009 -- Biocoat, Inc., Horsham, PA ann...
(Date:1/9/2009)..., LONDON, January 9 , ... Excelling in,Examinations and Tests at Whatever ...e Be Free From Partnership. It is,designed specif...erview,nerves. The service is EXAM AID and it can...site gives detailed personalized,instruction, the...
(Date:1/8/2009)..., NEW YORK, Jan. 8 New York Cit...009 "IBREA Brain Education Day" and presented a pr...national Brain Education Association) and develope...gnitive training to enhance health, well-being, an...ecognized thought leader regarding the power of in...
Breaking Medicine News(10 mins):Health News:Mach One Corporation Enters Letter of Intent to Acquire Ceres Organic Harvest, Inc. 2Health News:Blog Launched to Discuss Developments in Hydrophilic Coatings for Medical Devices 2Health News:Be Free From Exam Nerves 2Health News:NYC Mayor Michael R. Bloomberg Declares January 8th 'IBREA Brain Education Day' 2
...take the consent of patients prior to medical tria...ng// medical trials without obtaining approval fro...rpool, found himself in a blind spot after he inse...eyes as part of a study. Following this, Mr. Chitk...
...t the Aberdeen University it was found that women ...st results//. They experience unnecessarily high l...who had previously taken up the cervical smear tes... About 3,000 new cases are diagnosed every year. I...
...tance into various medical courses offered by unai...dical education and research department// of the P...HMS, BAMS and other similar medical and paramedica...nstitutions and students have also been invited fo...
...administrators said that they are requesting patie...t 300 morbidly obese patients// for a blood test f... San Diego, California said that a nurse had faile...n instrument called a gastroscope. It is used in t...
Other Medicine News:Health News:Provisional Fees For Medical Courses Fixed By Punjab Government 2
(Date:1/7/2009)...ased On Osteotech,s Proprietary Human Collagen Tec...Filing Anticipated in Third Quarter 2009 , , E... Osteotech, Inc. (Nasdaq: OSTE ), a leader in th...tive healing, announced today that it has initiate...oRegeneration Matrix. The first five patients in t...
(Date:1/6/2009)... prior U.S., U.K. and China Trials , , SAN DIEG...TI), a development stage company targeting liver d...un for a randomized, controlled, multi-center, Pha...real Liver Assist Device (ELAD) as a treatment for...ee protocols. The study is open for enrollment at ...
(Date:1/6/2009)...- The Michael J. Fox Foundation awarded a total of...s for pre-clinical research on potential new treat...was awarded under the Foundation,s Therapeutics D...ed in 2006, supports and bolsters industry-focused... MJFF,s focus on ,de-risking, preclinical PD res...
(Date:1/6/2009)...-- Pacira Pharmaceuticals, Inc., an,acute care sp...at enrollment,has been completed in two pivotal P... efficacy of a single intraoperative administratio...postoperative analgesia. , Results from the...throplasty (TKA) are expected to provide the prima...
Breaking Medicine Technology:Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3Hospital of the Future Report Urges Major Changes 30237 1Hospital of the Future Report Urges Major Changes 30237 2Hospital of the Future Report Urges Major Changes 30237 3Hospital of the Future Report Urges Major Changes 30237 4Hospital of the Future Report Urges Major Changes 30237 5Texting Food Diaries Helps Kids Stick With Diets 30235 1Texting Food Diaries Helps Kids Stick With Diets 30235 2Texting Food Diaries Helps Kids Stick With Diets 30235 3Epocrates Offers International Market Research Panel 30234 1Epocrates Offers International Market Research Panel 30234 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3464 1Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3464 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3464 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3464 4
...ility to Function and Treatment of Anxious,and Pai...21, 2007 /PRNewswire-FirstCall/ -- Data,suggest th...),treated with Cymbalta(R) (duloxetine HCl) experi...ies at home, work and in social,situations compare...tioning were the result of improvements in anxious...
...PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE),today a...n,s (FDA),San Juan District Office has informed th... Guayama, Puerto Rico manufacturing,facility has r...te.,The new classification means that any issues f...Company or do not merit any further,regulatory act...
Other Medicine Technology:Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 2Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 3Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 4Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 5Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 6FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 2FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 3
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: